★ Nootropic

DSIP

Nootropic · 5mg × 10 vials

it does not knock you out, it nudges the brain into the deep restorative phase of sleep that most poor sleepers spend too little time in.

✓ 98%+ Purity ✓ Lab Tested ✓ COA on Request ✓ Discreet Shipping ✓ Direct Support
📋 Certificate of Analysis Request the third-party COA via Telegram
Quick Start
🧪
Format
Injectable (reconstituted) · 5mg × 10 vials
🎯
Who it's for
poor sleep depth
💉
How it's run
100 mcg SubQ
When you'll notice
same night
Pricing
$75from · kit of 10
In US stock · 2-5 day UPS 2nd Day Air
+ $40 ship · singles $20 · free over $1k per tier
5mg × 10 vials$75
10mg × 10 vials$130
15mg × 10 vials$170
Order / Consult on Telegram →
0 min plasma (functional sleep effect persists hours / nights)
Half-life
as-needed
Cycling
same night
First effects
nootropic
Class
Overview

What Is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated in 1977 by the Schoenenberger and Monnier group at Basel from rabbit cerebral venous blood after low-frequency electrical stimulation of the intralaminar thalamic nuclei. It crosses the blood-brain barrier intact and shifts EEG architecture toward slow-wave (delta) activity, with the original characterisation studies showing roughly a 35% increase in delta activity in the neocortex and limbic cortex versus controls. It is not a sedative and does not bind GABA receptors directly; instead it modulates the sleep-wake system through stress-axis dampening (it attenuates stress-induced cortisol/corticosterone elevation), opioid-receptor adjacent activity (which is why it ameliorates opioid and alcohol withdrawal), and direct delta-wave promotion. In plain language: it does not knock you out, it nudges the brain into the deep restorative phase of sleep that most poor sleepers spend too little time in. Plasma half-life is short (~7-15 minutes by aminopeptidase/endopeptidase clearance), but the downstream effect on sleep architecture is long, with some users reporting better sleep for several nights after a single dose.

Protocols

Typical dose ranges by experience level - educational reference. Message us and we tailor it to you.

Protocol100 mcg SubQ
Frequency1-3 nights per week, NOT daily
Duration4-week assessment window; this is an as-needed compound, not a continuous-use one

Community lead Dr. William Seeds protocol is 100 mcg subQ ~3 hours before bedtime. Many first-timers don't feel anything for the first 3-4 doses, then suddenly notice better morning recovery. Pair with consistent bedtime and a dark room or the delta shift gets wasted.

Protocol200-300 mcg SubQ
Frequency3-5 nights per week on the nights you most need depth (training days, high-stress days)
DurationRun on the nights you need it. No continuous dosing.

Ben Greenfield runs 150 mcg, 3 nights per week to avoid tolerance. Jordan's house protocol for customer DMs is 200-400 mcg, 3-5x weekly, in 4-6 week cycles followed by an equal break. The break is the lever that keeps it working.

Protocol300-500 mcg SubQ
Frequency3-5 nights per week, never every night
Duration4-6 weeks on, then 4-6 weeks off, repeat as needed

Top-end users almost always pair with Selank, oxytocin, or epithalon rather than push DSIP higher in isolation. The advanced move is stacking, not dose escalation.

What To Expect
same night
Some users
3-4 nights
Most
Side Effects

Straight talk - what people actually report, and what the studies measured.

What users report
From forums, Discord & TikTok
  • "Felt nothing": the #1 community complaint. Either timing was wrong (too close to bedtime, too far before), dose was too low, or the product was degraded.
  • - Divergence: Clinical trials show statistically significant EEG delta increases; community is split 50/50 on subjective improvement. The objective measurement and the felt-effect don't always line up.
  • Paradoxical wired/arousal at 500 mcg+: reported often enough that community guides flag it as a real ceiling
  • Tolerance buildup with daily dosing: users running it every night report it stops working after 1-2 weeks (suspected delta-opioid receptor downregulation); the fix is to dose 3-5x per week, not daily
  • Mild temperature elevation: occasional report, transient
  • Vivid dreams: reported by a subset, sometimes positive ("more REM"), sometimes disruptive
  • Dose inconsistency: huge variance in subjective response between batches, between vials, and even between draws from the same vial. Storage and reconstitution discipline matters more for DSIP than for most peptides.
What the studies show
Measured in clinical trials
  • Headache: transient, mild, most-reported (Pollard & Pomfrett 2001)
  • Nausea: transient, mild
  • Vertigo / dizziness: transient
  • Injection-site reaction: mild redness, resolves
  • No lethal dose established in animal studies, described as "incredibly safe" in the peer-reviewed safety review
  • No significant cardiovascular, hormonal, or hepatic signal in human trials
The Research

Peer-reviewed studies and clinical guidelines - tap any to read the source.

PubMedSchoenenberger & Monnier 1977, Characterization of a delta-EEG-sleep-inducing peptide (PMC430668)

](https://pmc.ncbi.nlm.nih.gov/articles/PMC430668/) - original isolation, sequence determination, 35% delta increase

Read study ↗
PubMedSchneider-Helmert & Schoenenberger 1981, Influence of synthetic DSIP on disturbed human sleep

human sleep architecture data in insomniacs

Read study ↗
PubMedKovalzon & Strekalova 1987/2006, DSIP an update

review of cortisol, LH, somatotropin modulation

Read study ↗
PubMedDick et al, Successful treatment of withdrawal symptoms with DSIP (PMID 6328354)

](https://pubmed.ncbi.nlm.nih.gov/6328354/) - 67-patient series, 97% opioid and 87% alcohol withdrawal symptom relief

Read study ↗
PubMedDelta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke, Molecules 2021

intranasal route, neuroprotective signal

Read study ↗
PubMedPichia pastoris DSIP-CBBBP fusion peptide in PCPA-induced insomnia, 2024 (PMC11498945)

](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11498945/) - modern BBB-penetrant DSIP research

Read study ↗
+ 5 more studies & references
From The Community

Aggregated sentiment from public forums & socials - real-world reports, not individual endorsements.

RRealPeptides DSIP myth

"Felt nothing": the #1 community complaint. Either timing was wrong (too close to bedtime, too far before), dose was too low, or the product was degraded.

RRealPeptides DSIP not

- Divergence: Clinical trials show statistically significant EEG delta increases; community is split 50/50 on subjective improvement. The objective measurement and the felt-effect don't always line up.

PPeptides.org DSIP nasa

Paradoxical wired/arousal at 500 mcg+: reported often enough that community guides flag it as a real ceiling

CCalcMyPeptide DSIP dos

Tolerance buildup with daily dosing: users running it every night report it stops working after 1-2 weeks (suspected delta-opioid receptor downregulation); the fix is to dose 3-5x per week, not daily

RRealPeptides DSIP myth

Mild temperature elevation: occasional report, transient

RRealPeptides DSIP not

Vivid dreams: reported by a subset, sometimes positive ("more REM"), sometimes disruptive

Common Questions
SubQ (primary). Intranasal route also studied and used by some prescribing peptide clinics, but the PP supply is injectable..
same night for some users, 3-4 nights for most
A popular pairing is DSIP + Selank. See the Protocols section, or ask us for a stack built around your goal.
Yes. Every batch is third-party lab tested - request the COA on Telegram and we send it over.
Safety & Contraindications

Hard stops

  • Pregnancy or breastfeeding
  • Active cancer history (peptide-class precaution)
  • Concurrent naloxone or other opioid antagonist (blocks DSIP effect per Dr. Seeds)

Caution flags

  • Concurrent peptidase-inhibiting medications (e.g., captopril for hypertension)
  • History of severe sleep apnea (DSIP deepens sleep; deeper sleep in untreated apnea can worsen oxygen desaturation episodes)
  • Existing benzodiazepine or z-drug use (no documented interaction but compounding sedation isn't worth it)
  • History of paradoxical reactions to sedatives

Stacking conflicts

  • Daily stacking with high-dose opioid analgesics (DSIP and opioids share receptor activity, additive effects unclear)
  • Do not combine with melatonin doses >5 mg in the same window (no harm but the combo flattens DSIP's signal in user reports)
Is It Right For You?

✓ Good fit

  • poor sleep depth
  • restorative-sleep complaint
  • athletic recovery
  • stress-related insomnia
  • opioid taper support
  • GLP-1 users with deficit-induced bad sleep
  • stack with Selank

✗ Not a fit

  • sleep-onset insomnia only
  • customers expecting a sedative
  • pregnancy
  • active cancer
  • daily compulsive dosers
  • dose-tweakers who won't stick to one protocol for 4 weeks

Administration & Storage

Route: SubQ (primary). Intranasal route also studied and used by some prescribing peptide clinics, but the PP supply is injectable.

Injection site: abdomen or outer thigh, rotate sites. Subcutaneous, very small needle.

Storage: refrigerated 2-8 C, ~14 days after reconstitution per community consensus. Lyophilised vials store best at -20 C; refrigerator-only storage of the dry powder degrades potency.

Notes: Inject 1-3 hours before desired bedtime so the delta-shift effect lines up with sleep onset. Do not freeze the reconstituted vial. Use BAC water, not sterile water (sterile water has no preservative and contaminates fast). Inject the BAC down the side of the vial, do not jet it onto the powder cake or you foam the peptide and lose potency.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.